间充质基质细胞外囊泡通过调控巨噬细胞炎症小体改善免疫检查点抑制剂相关肺炎OA
Mesenchymal stromal cell-derived extracellular vesicles alleviate immune checkpoint inhibitor-related pneumonitis by regulating macrophage inflammasome activation
目的:探讨间充质基质细胞来源细胞外囊泡(MSC-EV)对小鼠免疫检查点抑制剂相关肺炎(CIP)模型的改善作用及分子机制.方法:选取Foxp3DTR小鼠,皮下接种MC38小鼠结肠癌细胞,待肿瘤生长至可触及后,随机分为3组(每组n=6):①对照组;②CIP模型组[接种MC38细胞后腹腔注射白喉毒素(DT)及anti-PD-1抗体,构建Treg细胞耗竭联合anti-PD-1抗体诱导的小鼠CIP模型];③MSC-EV干预组(CIP模型基础上,经鼻滴注MSC-EV干预,剂量109个/只,每3天1次,共2次).体内实验采用H-E染色观察肺组织病理损伤,测定肺干湿比评估肺水肿程度,ELISA检测支气管肺泡灌洗液(BALF)中IL-1β、IL-6及TNF-α水平,流式细胞术检测BALF中Ly6G⁺粒细胞浸润比例,监测肿瘤体积评价抗肿瘤疗效.体外实验采用DiO荧光标记观察细胞外囊泡(EV)被骨髓来源巨噬细胞摄取的情况,WB法检测NOD样受体家族含Pyrin域蛋白3(NLRP3)炎症小体关键蛋白(剪切型GSDMD、成熟型IL-1β)的表达水平.结合GEO数据库miRNA测序数据(GSE69909)、Dicer敲低及miR-21/miR-125抑制剂干预揭示潜在机制.结果:MSC-EV经鼻滴注可减轻CIP模型小鼠肺部炎症损伤,降低BALF中IL-1β、IL-6、TNF-α水平及Ly6G⁺粒细胞浸润比例(P<0.05),且不削弱anti-PD-1抗体的抗肿瘤疗效.体外DiO标记示踪显示MSC-EV可被巨噬细胞摄取,WB法检测结果显示,MSC-EV可降低NLRP3炎症小体关键活化蛋白(剪切型GSDMD、成熟型IL-1β)水平(P<0.05).体 外 实 验 中,Dicer敲低后制备 的MSC-EV 对巨噬细胞IL-1β的下调作用减弱(P<0.05).miRNA测序显示miR-21、miR-125在MSC-EV中高表达,抑制miR-21或miR-125后,相应MSC-EV对巨噬细胞IL-1β剪切的抑制作用降低(P<0.05).结论:MSC-EV通过其携带的miR-21和miR-125等miRNA发挥抗炎效应,其机制可能与抑制巨噬细胞NLRP3炎症小体活化有关,可有效改善CIP且不影响免疫检查点抑制剂的抗肿瘤疗效.
Objective:To investigate the therapeutic effect and molecular mechanism of mesenchymal stromal cell-derived extracellular vesicles(MSC-EV)on immune checkpoint inhibitor-related pneumonitis(CIP)in a mouse model.Methods:Foxp3DTR mice were inoculated with MC38 mouse colon cancer cells and randomly divided into 3 groups(n=6 per group):① control group(MC38 inoculation only);② CIP model group(inoculated with MC38 cells,intraperitoneally injected with diphtheria toxin[DT]and anti-PD-1 antibody);③ MSC-EV intervention group(based on the CIP model,intranasally administered with MSC-EV[dose 109 particles/mouse,every 3 days,2 times in total]).A mouse CIP model induced by Treg depletion combined with anti-PD-1 antibody was established.In vivo,H-E staining was used to observe lung pathological injury,lung wet/dry ratio was measured to assess pulmonary edema,ELISA was used to detect IL-1β,IL-6,and TNF-α levels in bronchoalveolar lavage fluid(BALF),and flow cytometry was used to detect the proportion of Ly6G ⁺ granulocyte infiltration in BALF.Tumor volume was monitored to evaluate antitumor efficacy.In vitro,DiO fluorescent labeling was used to observe the uptake of extracellular vesicles(EVs)by bone marrow-derived macrophages,and WB assay was used to detect the expression levels of key NLRP3 inflammasome proteins(cleaved GSDMD and mature IL-1β).Potential mechanisms were explored using GEO database miRNA sequencing data(GSE69909),Dicer knockdown,and miR-21/miR-125 inhibitor intervention.Results:Intranasal administration of MSC-EV alleviated lung inflammatory injury in CIP model mice,reduced IL-1β,IL-6,and TNF-α levels and the proportion of Ly6G⁺ granulocyte infiltration in BALF(P<0.05),without compromising the antitumor efficacy of anti-PD-1 antibody therapy.In vitro DiO labeling tracing showed that MSC-EV could be taken up by macrophages.WB assay showed that MSC-EV decreased the levels of key activated proteins(cleaved GSDMD and mature IL-1β)of the NLRP3 inflammasome(P<0.05).In vitro,after Dicer knockdown,the MSC-EV showed a weakened downregulation effect on IL-1β in macrophages(P<0.05).miRNA sequencing(GEO database,GSE69909)showed high expression of miR-21 and miR-125 in MSC-EV,and inhibition of miR-21 or miR-125 reduced the inhibitory effect of the corresponding MSC-EV on IL-1β cleavage in macrophages(P<0.05).Conclusion:MSC-EV exert anti-inflammatory effects through their carried miRNAs such as miR-21 and miR-125,and the mechanism may be related to inhibition of NLRP3 inflammasome activation in macrophages,thereby effectively alleviating CIP without compromising the antitumor efficacy of immune checkpoint inhibitor.
肖淑妍;薛丰沅;季殷敏;吕雅晖;董怡;胡毅
中国人民解放军医学院 临床医学系,北京 100853||中国人民解放军总医院第一医学中心 肿瘤内科,北京 100853中国人民解放军医学院 临床医学系,北京 100853中国人民解放军总医院第五医学中心肿瘤医学部,北京 100039中国人民解放军医学院 临床医学系,北京 100853中国人民解放军医学院 临床医学系,北京 100853||中国人民解放军总医院第一医学中心 肿瘤内科,北京 100853中国人民解放军总医院第一医学中心 肿瘤内科,北京 100853||中国人民解放军总医院第五医学中心肿瘤医学部,北京 100039
医药卫生
细胞外囊泡间充质基质细胞免疫检查点抑制剂相关肺炎巨噬细胞NLRP3炎症小体
extracellular vesicle(EV)mesenchymal stromal cell(MSC)immune checkpoint inhibitor-related pneumonitis(CIP)macrophageNLRP3 inflammasome
《中国肿瘤生物治疗杂志》 2026 (5)
521-527,7
评论